NCT05701150 AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT
| NCT ID | NCT05701150 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AIO-Studien-gGmbH |
| Condition | Advanced Solid Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2022-12-08 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2022-12-08 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
National, retro- and prospective, observational, multicenter clinical research platform to connect clinical and genomic data of patients with advanced (locally advanced, inoperable, or metastatic) solid tumors (excluding NSCLC, SCLC, and mesothelioma) with results from multi-gene next-generation sequencing (NGS) panels (\>30 genes)
Eligibility Criteria
Inclusion Criteria: * Diagnosis of advanced (i.e., locally advanced, inoperable, or metastatic) solid tumor, ineligible for curative surgery and/or curative systemic therapy * Available results of commercial or non-commercial RNA- and/or DNA-based multi-gene NGS panels with \>30 genes analyzed; for non-commercial panels a list of all tested genes and multiple gene biomarkers (e.g., tumor mutational burden (TMB), microsatellite status) must be provided * Age ≥ 18 years * Signed and dated informed consent form (not applicable for inclusion of deceased patients) Exclusion Criteria: * Diagnosis of NSCLC/SCLC (C34) or mesothelioma (C45) * NGS results older than two years at the date of patient inclusion
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05701150 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Advanced Solid Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05701150 currently recruiting?
Yes, NCT05701150 is actively recruiting participants. Contact the research team at marc.fischer@aio-studien-ggmbh.de for enrollment information.
Where is the NCT05701150 trial being conducted?
This trial is being conducted at Freiburg im Breisgau, Germany, Mannheim, Germany, München, Germany.
Who is sponsoring the NCT05701150 clinical trial?
NCT05701150 is sponsored by AIO-Studien-gGmbH. The trial plans to enroll 3,000 participants.